Profile	GDS4460 / 205883_at
Title	Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM803586	patient 6, baseline	391.9	88
GSM803589	patient 7, baseline	386.5	87
GSM803592	patient 8, baseline	50.8	55
GSM803595	patient 10, baseline	534.3	91
GSM803598	patient 11, baseline	33.5	51
GSM803601	patient 12, baseline	65.8	60
GSM803604	patient 13, baseline	222.7	80
GSM803607	patient 14, baseline	140	73
GSM803610	patient 15, baseline	186.3	78
GSM803613	patient 16, baseline	36.5	52
GSM803587	patient 6, arm treated with pimecrolimus	155.9	75
GSM803590	patient 7, arm treated with pimecrolimus	1022.6	95
GSM803593	patient 8, arm treated with pimecrolimus	98.8	67
GSM803605	patient 13, arm treated with pimecrolimus	200.6	79
GSM803608	patient 14, arm treated with pimecrolimus	284.2	84
GSM803599	patient 11, arm treated with pimecrolimus	169.7	76
GSM803611	patient 15, arm treated with pimecrolimus	270.4	83
GSM803614	patient 16, arm treated with pimecrolimus	130.3	72
GSM803602	patient 12, arm treated with pimecrolimus	277	83
GSM803596	patient 10, arm treated with pimecrolimus	1561.4	97
GSM803591	patient 8, arm treated with betamethasone	58.5	59
GSM803609	patient 15, arm treated with betamethasone	1192.6	96
GSM803597	patient 11, arm treated with betamethasone	440.8	89
GSM803585	patient 6, arm treated with betamethasone	340.2	86
GSM803603	patient 13, arm treated with betamethasone	928.6	95
GSM803612	patient 16, arm treated with betamethasone	235	81
GSM803588	patient 7, arm treated with betamethasone	1376.2	97
GSM803594	patient 10, arm treated with betamethasone	1050.5	96
GSM803600	patient 12, arm treated with betamethasone	1035.4	96
GSM803606	patient 14, arm treated with betamethasone	1372.4	97